Abatacept: a review of its use in the management of rheumatoid arthritis.
about
Pharmacotherapy for uveitis: current management and emerging therapy.Pneumocystis jirovecii Pneumonia in a Patient with Rheumatoid Arthritis Treated with AbataceptIn search of magic bullets: the golden age of immunotherapeutics.Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantationPrognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study.Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy.Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways.Safety profile of biological therapies for treating rheumatoid arthritis.Abatacept for the treatment of systemic lupus erythematosus.Immunology proves a great success for treating systemic autoimmune diseases - a perspective on immunopharmacology: IUPHAR Review 23.A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business.Abatacept: A Review in Rheumatoid Arthritis.Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis.ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution.Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression.Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options.Molecular Mechanisms of T Cells Activation by Dendritic Cells in Autoimmune Diseases
P2860
Q34274075-50633759-2187-412C-B131-47DA83E78908Q34278716-F14D7E24-FEE5-4E1C-9F95-CAB34C34B096Q34356481-2CD43024-61C9-4AAC-9ED3-F42211B35284Q34991001-035DEBA3-AEF8-4FA1-B7D0-7D9339FCDEC9Q35728708-0A948BF4-D7D1-4D73-A9AB-13A37F352A69Q36484383-B408376E-DB38-4007-8848-69585BD702B2Q38391212-99D40C3E-5631-465B-90E3-B9720607C30DQ38597826-CAF40C9D-7B68-4072-9A74-5ED2E95B3AEDQ38665700-9B74559A-A22B-43F3-945E-25D5B131F83EQ38734009-BD89A108-DF0A-4D11-A9FD-999FC2652520Q38744431-64065EFC-47B2-41E9-BE6F-6305DA4231CBQ38937842-510F8957-EA19-4796-A680-9FF788F0DA62Q39368606-650A5CFD-7928-46D3-9877-F0BE4A2FBB2CQ47129849-C1352D14-C951-44FD-9C50-D292A9CCC674Q51450251-951086AC-2049-4517-B530-9882BA3E8C5BQ51644633-40215438-1C89-434C-B9AC-2D07273F0E63Q53081333-D2BC13E9-C44D-4465-AB05-293F651AE6ECQ55315323-93F2A3AB-DE74-400B-9929-E3B4681FC7C6Q56891645-66B6FA0F-BFCD-47B8-B9FC-998346356ED4
P2860
Abatacept: a review of its use in the management of rheumatoid arthritis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Abatacept: a review of its use in the management of rheumatoid arthritis.
@en
type
label
Abatacept: a review of its use in the management of rheumatoid arthritis.
@en
prefLabel
Abatacept: a review of its use in the management of rheumatoid arthritis.
@en
P2860
P1433
P1476
Abatacept: a review of its use in the management of rheumatoid arthritis.
@en
P2860
P2888
P304
P356
10.1007/S40265-013-0080-9
P577
2013-07-01T00:00:00Z
P6179
1001475360